{"id":44395,"date":"2022-05-26T19:02:02","date_gmt":"2022-05-26T17:02:02","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/"},"modified":"2022-05-26T19:02:02","modified_gmt":"2022-05-26T17:02:02","slug":"north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/","title":{"rendered":"North America Clinical Trials Market Report to 2031 &#8211; Featuring Clinipace, Pfizer and SGS Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5569577\/north-america-clinical-trials-market-2021-2031-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=wbcfck&amp;utm_campaign=1705695+-+North+America+Clinical+Trials+Market+Report+to+2031+-+Featuring+Clinipace%2C+Pfizer+and+SGS+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;North America Clinical Trials Market 2021-2031 by Product Category, Phase, Design, Service Type, Indication, End User, and Country: Trend Forecast and Growth Opportunity&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220526005655\/en\/1468735\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220526005655\/en\/1468735\/21\/logo.jpg\"><\/a><\/p>\n<p>\nNorth America clinical trials market is projected to grow by 6.9% annually in the forecast period and reach $39,268.7 million by 2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&amp;D investments.\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAccell Clinical Research LLC\n<\/li>\n<li>\nCharles River Laboratory\n<\/li>\n<li>\nClinDatrix Inc\n<\/li>\n<li>\nClinipace\n<\/li>\n<li>\nEli Lilly and Company\n<\/li>\n<li>\nF. Hoffmann-La Roche Ltd.\n<\/li>\n<li>\nICON PLC\n<\/li>\n<li>\nIQVIA Holdings, Inc.\n<\/li>\n<li>\nLaboratory Corporation of America\n<\/li>\n<li>\nNovo Nordisk AS\n<\/li>\n<li>\nPAREXEL International Corporation\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nPharmaceutical Product Development LLC\n<\/li>\n<li>\nPRA Health Sciences\n<\/li>\n<li>\nSanofi SA\n<\/li>\n<li>\nSGS SA\n<\/li>\n<li>\nSyneos Health Inc.\n<\/li>\n<li>\nWuxi AppTec Inc.\n<\/li>\n<\/ul>\n<p>\nThis report is based on a comprehensive research of the entire North America clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.\n<\/p>\n<p>\n<strong>In-depth qualitative analyses include identification and investigation of the following aspects:<\/strong>\n<\/p>\n<ul>\n<li>\nMarket Structure\n<\/li>\n<li>\nGrowth Drivers\n<\/li>\n<li>\nRestraints and Challenges\n<\/li>\n<li>\nEmerging Product Trends &amp; Market Opportunities\n<\/li>\n<li>\nPorter&#8217;s Five Forces\n<\/li>\n<\/ul>\n<p>\nThe trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Country.\n<\/p>\n<p>\n<strong>Based on Product Category, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nTrials of Drugs\n<\/li>\n<li>\nSmall Molecule Drugs\n<\/li>\n<li>\nVaccines\n<\/li>\n<li>\nCell &amp; Gene Therapy\n<\/li>\n<li>\nOther Drugs\n<\/li>\n<li>\nTrials of Devices\n<\/li>\n<li>\nTrials of Procedures\n<\/li>\n<\/ul>\n<p>\n<strong>Based on Phase, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nPhase I\n<\/li>\n<li>\nPhase II\n<\/li>\n<li>\nPhase III\n<\/li>\n<li>\nPhase IV\n<\/li>\n<\/ul>\n<p>\n<strong>By Design, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nInterventional Studies\n<\/li>\n<li>\nRandomized Control Trial\n<\/li>\n<li>\nAdaptive Clinical Trial\n<\/li>\n<li>\nNon-randomized Control Trial\n<\/li>\n<li>\nObservational Studies\n<\/li>\n<li>\nCohort Study\n<\/li>\n<li>\nCase Control Study\n<\/li>\n<li>\nCross Sectional Study\n<\/li>\n<li>\nEcological Study\n<\/li>\n<li>\nExpanded Access Trials\n<\/li>\n<\/ul>\n<p>\n<strong>By Service Type, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nProtocol Designing\n<\/li>\n<li>\nSite Identification\n<\/li>\n<li>\nPatient Recruitment\n<\/li>\n<li>\nLaboratory Services\n<\/li>\n<li>\nBioanalytical Testing Services\n<\/li>\n<li>\nClinical Trial Data Management Services\n<\/li>\n<li>\nClinical Trial Supply &amp; Logistic Services\n<\/li>\n<li>\nDecentralized Clinical Trial Services\n<\/li>\n<li>\nMedical Device Testing Services\n<\/li>\n<li>\nOther Clinical Trial Services\n<\/li>\n<\/ul>\n<p>\n<strong>By Indication, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nOncology\n<\/li>\n<li>\nInfectious Diseases\n<\/li>\n<li>\nCardiology\n<\/li>\n<li>\nObesity\n<\/li>\n<li>\nDiabetes\n<\/li>\n<li>\nNeurology\n<\/li>\n<li>\nImmunology\n<\/li>\n<li>\nPain Management\n<\/li>\n<li>\nOther Indications\n<\/li>\n<\/ul>\n<p>\n<strong>By End User, the North America market is segmented into the following sub-markets with annual revenue ($mn) for 2021-2031 included in each section.<\/strong>\n<\/p>\n<ul>\n<li>\nPharmaceutical and Biotechnological Companies\n<\/li>\n<li>\nClinical Research Organizations\n<\/li>\n<li>\nClinical Testing Laboratories\n<\/li>\n<li>\nOther End Users\n<\/li>\n<\/ul>\n<p>\n<strong>Geographically, the following national\/local markets are fully investigated:<\/strong>\n<\/p>\n<ul>\n<li>\nU.S.\n<\/li>\n<li>\nCanada\n<\/li>\n<li>\nMexico\n<\/li>\n<\/ul>\n<p>\nFor each key country, detailed analysis and data for annual revenue ($mn) are available for 2021-2031. The breakdown of national markets by Phase, Design, and Indication over the forecast years are also included.\n<\/p>\n<p>\nThe report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5569577\/north-america-clinical-trials-market-2021-2031-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=wbcfck&amp;utm_campaign=1705695+-+North+America+Clinical+Trials+Market+Report+to+2031+-+Featuring+Clinipace%2C+Pfizer+and+SGS+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/50pw9g<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#105;&#x6c;&#x74;&#111;&#58;&#x70;&#x72;&#101;&#115;&#x73;&#x40;&#114;&#101;&#x73;&#x65;&#97;&#114;&#x63;&#x68;&#97;&#110;&#x64;&#x6d;&#97;&#114;&#x6b;&#x65;&#116;&#115;&#x2e;&#x63;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#x65;&#115;&#115;&#64;re&#x73;&#x65;&#x61;&#x72;&#99;&#104;an&#x64;&#x6d;&#x61;&#x72;&#107;&#101;ts&#x2e;&#x63;&#x6f;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;North America Clinical Trials Market 2021-2031 by Product Category, Phase, Design, Service Type, Indication, End User, and Country: Trend Forecast and Growth Opportunity&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. North America clinical trials market is projected to grow by 6.9% annually in the forecast period and reach $39,268.7 million by 2031, driven &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44395","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>North America Clinical Trials Market Report to 2031 - Featuring Clinipace, Pfizer and SGS Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"North America Clinical Trials Market Report to 2031 - Featuring Clinipace, Pfizer and SGS Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;North America Clinical Trials Market 2021-2031 by Product Category, Phase, Design, Service Type, Indication, End User, and Country: Trend Forecast and Growth Opportunity&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. North America clinical trials market is projected to grow by 6.9% annually in the forecast period and reach $39,268.7 million by 2031, driven ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-26T17:02:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220526005655\/en\/1468735\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"North America Clinical Trials Market Report to 2031 &#8211; Featuring Clinipace, Pfizer and SGS Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-05-26T17:02:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\\\/\"},\"wordCount\":692,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220526005655\\\/en\\\/1468735\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\\\/\",\"name\":\"North America Clinical Trials Market Report to 2031 - Featuring Clinipace, Pfizer and SGS Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220526005655\\\/en\\\/1468735\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-05-26T17:02:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220526005655\\\/en\\\/1468735\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220526005655\\\/en\\\/1468735\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"North America Clinical Trials Market Report to 2031 &#8211; Featuring Clinipace, Pfizer and SGS Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"North America Clinical Trials Market Report to 2031 - Featuring Clinipace, Pfizer and SGS Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"North America Clinical Trials Market Report to 2031 - Featuring Clinipace, Pfizer and SGS Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;North America Clinical Trials Market 2021-2031 by Product Category, Phase, Design, Service Type, Indication, End User, and Country: Trend Forecast and Growth Opportunity&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. North America clinical trials market is projected to grow by 6.9% annually in the forecast period and reach $39,268.7 million by 2031, driven ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-26T17:02:02+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220526005655\/en\/1468735\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"North America Clinical Trials Market Report to 2031 &#8211; Featuring Clinipace, Pfizer and SGS Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-05-26T17:02:02+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/"},"wordCount":692,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220526005655\/en\/1468735\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/","name":"North America Clinical Trials Market Report to 2031 - Featuring Clinipace, Pfizer and SGS Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220526005655\/en\/1468735\/21\/logo.jpg","datePublished":"2022-05-26T17:02:02+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220526005655\/en\/1468735\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220526005655\/en\/1468735\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/north-america-clinical-trials-market-report-to-2031-featuring-clinipace-pfizer-and-sgs-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"North America Clinical Trials Market Report to 2031 &#8211; Featuring Clinipace, Pfizer and SGS Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44395"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44395\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}